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Abstract
Background: Adequate pain control through sedation and anesthesia for emergency procedures is a crucial aspect
of pediatric emergency care. Resources for administering such anesthesia are extremely limited in many low-income
settings.
Methods: Non-anesthetist providers in Western Kenya were trained in the use of a ketamine-based sedation and
anesthesia package for non-anesthetists, Every Second Matters for Mothers and Babies-Ketamine™ (ESM-Ketamine). Data
on use and safety of this package for emergent and urgent pediatric procedures was collected. Providers were
surveyed as to what they would have done for similar procedures if the ESM-Ketamine package were unavailable.
Results: Ninety procedures were completed for 77 pediatric patients utilizing the ESM-Ketamine package. Of these, 29
(32.2 %) cases were orthopedic reductions, 19 (21.1 %) were incision and drainage, and 19 (21.1 %) were debridement
and irrigation of burns. Remaining cases included cesarean section, repair of perineal tear, foreign body removal,
arthrocentesis, laceration repair, exploratory laparotomy, excision of mass, paracentesis, and circumcision. There were
no serious adverse events in any of the cases, 17 % experienced minor adverse events including hypersalivation,
hallucinations, or brief, self-resolving, oxygen desaturations. Providers were surveyed for 80 of the 90 cases as to what
they would have done in the absence of the ESM-Ketamine package: in 26 cases (32.5 %), they reported they would
proceed with the procedure without any anesthesia or analgesia; in 15 (18.75 %), they reported they would
significantly delay the procedure while waiting for an anesthetist; in 13 (16.25 %), they reported they would attempt
referral to another facility; and in 26 (32.5 %), they reported they would try using an alternate form of analgesia,
primarily acetaminophen, ibuprofen, diclofenac, and/or diazepam. All surveyed providers reported they would use the
ESM-Ketamine package again in similar cases.
Conclusions: The ESM-Ketamine package, through the use of a simplified protocol and checklist, allows for safe
analgesia and anesthesia in children by non-anesthetists in a resource-limited setting for selected emergent and urgent
procedures. This package addresses a significant gap in the availability of anesthesia services in low-income settings
that would otherwise result in significant delays to procedures or proceeding with painful procedures with inadequate
analgesia.
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Background
Adequate pain control through analgesia, procedural
sedation, and general anesthesia is a critical component
of care for patients undergoing surgery and painful pro-
cedures [1]. This is particularly the case in children
undergoing emergency procedures, where inadequate
pain control may result in the inability to complete a
procedure, untoward complications of the procedure,
and significant distress to both child and parents [2].
Despite the widely recognized need for analgesia and
anesthesia during surgery and painful procedures for
adults and children, worldwide resources for administer-
ing such services are unevenly distributed and, in many
regions, such as sub-Saharan Africa, are extraordinarily
scarce [3]. The recent Lancet Commission on Global
Surgery estimates that five of the 7.2 billion people on
earth do not have access to emergency surgery and that
lack of access to anesthesia is one of the primary barriers
contributing to this situation [4]. This gap in the avail-
ability of safe anesthesia and analgesia in low- versus
high-income countries has been recognized across a var-
iety of geographic settings [5–7]. Some of the poorest
countries in the world have the lowest density of anes-
thetists and anesthesiologists [5]. This anesthesia gap
may be even more significant for children than for adult
patients, as provider training and comfort with pediatric
anesthesia and analgesia is especially uncommon in
many low-income settings where anesthesia-related mor-
bidity and mortality rates can be high [8–11].
Contributors to these negative outcomes are many, in-
cluding unreliable electricity sources and oxygen delivery,
inconsistent medication availability, inadequate facilities,
and, in particular, a lack of personnel trained in the safe
administration of sedation, anesthesia, and analgesia in
children [3, 11]. This may result in painful urgent and
emergent procedures in children being performed with
inadequate pain control or being delayed for unacceptable
amounts of time [12].
To address this anesthesia and analgesia gap for emer-
gency surgery and procedures, we developed a pilot pro-
gram, Every Second Matters for Mothers and Babies-
Ketamine™ (ESM-Ketamine), to train non-anesthetist
providers in the administration and monitoring of keta-
mine anesthesia and sedation. Ketamine has an excellent
demonstrated safety profile in pediatric patients, even in
settings with limited resources [12–14]. Ketamine is
inexpensive, widely available for distribution in sub-
Saharan Africa, and a particularly well-suited choice to
this setting as it provides both analgesic and dissociative
effect [12]. In addition, significant respiratory depression
and the need for ventilatory support, which can be chal-
lenging in settings where advanced airway experience
and supplies are often scarce, occur extremely rarely
with ketamine [15, 16].
Safety and effectiveness of the ESM-Ketamine package,
designed for cesarean section and other emergency and
painful life-improving procedures, has previously been
reported in a series of 193 patients, 58 of whom were in
the pediatric age group [17]. Here, we present outcomes
with the use of this package for anesthesia and sedation
analyzed specifically in 90 pediatric cases, including 53
pediatric cases which were included in the previous
series but not separately analyzed there [17]. Further, we
investigate the question as to what alternative ap-
proaches providers would have considered for perform-
ing painful procedures and surgeries in children if they
had not had access to this package.
Methods
As described previously, ESM-Ketamine is an evidence-
based training package consisting of a 5-day hands-on
training curriculum, clinical checklist (Fig. 1), wall chart,
ketamine, and equipment (e.g., bag-mask ventilation de-
vice, pulse oximeter) [17]. This evidence-based program
was developed by global health clinicians at Massachu-
setts General Hospital and Harvard Medical School and
implemented in close partnership with the Kenya Ministry
of Health and Maseno University School of Medicine
(Maseno, Kenya).
Beginning in December 2013, local non-anesthetist
clinicians within target facilities in rural Western Kenya
were trained in the ESM-Ketamine package. The initial
training roll out was focused on Sagam Community
Hospital and took place during the first week of December
2013. Subsequent expansion trained providers at Mbita,
Siaya, Maseno Mission, Yalla, and Nightingale Hospitals,
with a total of 28 providers trained. Hospital selection cri-
teria included facilities that have operating theaters and
doctors who could perform surgical procedures. Health-
care providers were selected by chief administrators from
these hospitals and were trained on the ESM-Ketamine
package. Training included modules on ketamine pharma-
cology, patient monitoring, oxygen delivery, newborn
resuscitation, complication identification and intervention,
and basic airway management (suction techniques, head-
tilt and chin-lift, jaw thrust, two-person bagging). Partici-
pating clinicians were then invited to utilize the ESM-
Ketamine package whenever they deemed a life-saving or
life-improving surgery or procedure was necessary but
were not able to obtain an anesthetist.
Data were collected prospectively by the clinician ad-
ministering ketamine in all cases of ESM-Ketamine use
at study facilities using a standardized ESM-Ketamine
clinical record form. The form included elements such
as patient age; patient weight; procedure performed;
whether an anesthetist was called; and, if unavailable,
details regarding why the anesthetist was unavailable.
Clinicians also recorded complications attributable to
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the use of ketamine and adverse events at the time they
occurred on the clinical record form. ESM-Ketamine
quality assurance auditors collected completed ESM-
Ketamine clinical record forms from the facilities on a
weekly basis. Serious adverse events were defined as
death, prolonged oxygen desaturation (more than 30 s)
below 92 %, or any anesthesia-related injury, and minor
adverse events were defined as brief oxygen desaturation
(<30 s) below 92 %, hallucinations, and hypersalivation.
In this present study, we examined all ESM-Ketamine
cases involving pediatric patients less than or equal to
18 years of age. The primary focus for analysis was
patient safety, including patient outcomes and adverse
events. In addition, we reviewed patient demographics
and types of procedures completed using ESM-
Ketamine. To determine how the option of ketamine
sedation affected the management of pediatric cases, we
interviewed ketamine providers who utilized the ESM-
Ketamine package. Providers were asked how each
patient in our series would have been approached if the
ESM-Ketamine package had not been available, as well
as how the provider might proceed with caring for a
similar patient in the future.
This study was reviewed and approved in advance by
the Kenya Ministry of Health, the institutional review
board of Partners HealthCare (Massachusetts General
Hospital, Boston, MA, USA), and the ethical review
board of Maseno University School of Medicine
(Maseno, Kenya).
Results
Cases
Over a 2-year period (December 13, 2013 to December
4, 2015), 90 life-saving or life-improving procedures
were completed for 77 pediatric patients utilizing the
ESM-Ketamine package. Of these, 32.2 % of cases were
closed/open orthopedic reduction, 21.1 % were incision
and drainage of an abscess, and 21.1 % were
Fig. 1 ESM-Ketamine safety checklist
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debridement and irrigation of burns. The remaining in-
stances of ESM-Ketamine use in patients ≤18 years of
age included obstetric/gynecologic procedures such as
emergency cesarean section or repair of intrapartum
perineal tear, foreign body removal, arthrocentesis, com-
plex (non-gynecological) laceration repair, exploratory
laparotomy, excision of mass, paracentesis, and circum-
cision (Table 1). The overall median dose of ketamine
used was 2.0 mg/kg (range 1.4–8.3 mg/kg), and the median
length of time needed to complete a procedure was 20 min
(range 5–90 min). In 10 of the 90 cases, a second agent,
either diazepam, tramadol, or diclofenac, was used in
addition to ketamine. The cases that required the least
amount of ketamine were arthrocentesis, closed orthopedic
reduction, incision and drainage, circumcision, and foreign
body removal. Longer, more complex procedures such as
exploratory laparotomy, cesarean section, and orthopedic
fracture reduction necessitated higher doses of ketamine.
Among these seven more complex cases, one subject,
undergoing open fracture reduction, experienced a minor
adverse event in the form of hallucinations. The three cases
of cesarean section took 35, 65, and 90 min, respectively.
The two cases of exploratory laparotomy took 42 and
60 min, respectively. The two cases of orthopedic reduc-
tion lasted 5 and 35 min, respectively.
Patient demographics
Of the 77 pediatric patients treated with the ESM-
Ketamine package, 36 (46.8 %) were female and 41
(53.2 %) were male. Ages ranged from 1 through
18 years, with a mean age of 10.6 years (Table 2).
Complications
In 15 (17 %) of the cases in which ESM-Ketamine was
used, the patient experienced a minor adverse event.
These reactions included hallucinations during recovery
(nine patients), hypersalivation (four patients, one of which
was given atropine), and fall in oxygen saturations <92 %
for <30 s in two patients that self-resolved. There were no
reported serious adverse events. None of the patients re-
quired cardiopulmonary resuscitation or bag-valve mask
ventilation. None of the procedures were aborted or unable
to be completed due to an adverse event.
Provider survey responses
Follow-up surveys were conducted with 18 out of 23
providers who were involved in pediatric cases at four
different hospitals to determine how they would have
managed each case before they received the ESM-
Ketamine package and training. Of the 28 total
trained providers, five had not been involved in any
pediatric cases at time of this study and five providers
could not be reached as they were not available in
Table 1 Pediatric procedures and surgeries for which the ESM-Ketamine anesthesia package was utilized
Procedure Number (%) Median ketamine dose (and range) (mg/kg) Median duration of procedure (and range) (min)
Arthrocentesis 4 (4.4) 2.0 (1.4–2.0) 20.0 (15.0–49.0)b
Cesarean section 3 (3.3) 5.5 (3.7–7.0) 65.0 (35.0–90.0)
Circumcision 1 (1.1) 2.8 (2.8–2.8) 13.0 (13.0–13.0)
Closed orthopedic reduction 27 (30.0) 2.0 (1.5–4.0) 18.2 (5.0–60.0)b
Complex laceration repair (non-gyn) 2 (2.2) 3.4 (3.0–3.8) 32.5 (25.0–40.0)
Debridement and irrigation of burns 19 (21.1) 2.9 (2.0–6.0) 20.0 (5.0–83.0)
Excision of mass 1 (1.1) 3.0 (3.0–3.0) 65.0 (65.0–65.0)
Exploratory laparotomy 2 (2.2) 6.0 (6.0–6.0) 51.0 (42.0–60.0)
Foreign body removal 6 (6.7) 3.0 (2.0–3.9)a 21.0 (11.0–30.0)
Gynecologic laceration repair 3 (3.3) 3.0 (2.0–4.9) 37.5 (15.0–60.0)b
Incision and drainage 19 (21.1) 2.0 (1.9–4.0) 20.0 (10.0–75.0)b
Open orthopedic reduction 2 (2.2) 5.6 (2.8–8.3) 20.0 (5.0–35.0)
Paracentesis 1 (1.1) 4.0 (4.0–4.0) 24.0 (24.0–24.0)
Total 90 2.0 (1.4–8.3) 20.0 (5.0–90.0)
aOne case did not have a weight recorded, and so dose/kg could not be calculated
b10 cases had only one dose of ketamine so did not have total time recorded
Table 2 Age ranges and gender for patients in whom the ESM-
Ketamine package was utilized
Age (years) Gender, N (%)
Female Male
0–1 0 0
1–4 8 (10.4) 6 (7.8)
5–12 11 (14.3) 21 (27.2)
13–18 17 (22.1) 14 (18.2)
Total 36 (46.8) 41 (53.2)
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person and their cellular phone numbers were no
longer active. As such, responses were collected for
80 of the 90 pediatric cases (88.9 %) from 18 pro-
viders with the following results: 26 (32.5 %) of the
procedures would have been done without any
anesthesia or analgesia, 15 (18.75 %) would have been
significantly delayed while the medical team waited
for an anesthetist to become available, 13 (16.25 %)
would have attempted referral to another facility that
had anesthesia services, and 26 (32.5 %) would have
been completed using an alternate form of anesthesia
and/or analgesia. In this final category, in terms of
which alternative drugs providers reported they would
use, providers reported, in the absence of ketamine,
they would use benzodiazepines (diazepam) plus pain
medications (paracetamol, diclofenac, or ibuprofen) in
16 (62 %) of the cases, benzodiazepines alone in four
(15 %), pain medicine alone in four (15 %), and local
anesthesia in two (8 %). The only benzodiazepine
available for use was diazepam, and the only pain
medications available were paracetamol, diclofenac,
and ibuprofen. One hundred percent of providers sur-
veyed stated that they would use ketamine again for
similar procedures in the future.
Discussion
Our study supports the well-established safety record of
ketamine for use in pediatric sedation and anesthesia. It
corroborates other series that have demonstrated that this
safety profile can be extended to the setting of limited re-
sources with proper training and protocols for use. Fur-
thermore, our study supports that the ESM-Ketamine
package can extend anesthesia and sedation capabilities
considerably for a wide variety of surgeries and painful
pediatric procedures that might otherwise be performed
with minimal or no analgesia/anesthesia or significantly
delayed. Our sedation package was well-accepted by pro-
viders in a resource-limited setting, who report they would
continue to use this package in future procedures. Thus,
ESM-Ketamine represents an important tool in addressing
the gap in pediatric anesthesia and analgesia that presently
exists in many low-income countries.
Regarding ESM-Ketamine’s safety profile, 77 children
underwent a total of 90 procedures using ketamine
anesthesia in our study. Among these patients, there were
no serious adverse events, defined as death, prolonged oxy-
gen desaturation (>30 s), or any anesthesia-related injury.
All adverse events reported were minor, with hallucinations
representing the most commonly reported minor adverse
event, followed by hypersalivation. These adverse event
rates are comparable to previously reported rates for keta-
mine administered in children in both high-income and
other low-income country settings [12, 16, 18].
The safety of the ESM-Ketamine package was enhanced
by employing a simplified safety checklist with standard-
ized ketamine dosing as well as including training in the
management of potential complications. Airway events in-
cluding laryngospasm, obstruction, and apnea are rarely
reported with ketamine in the pediatric literature, and
none occurred in our series of 90 cases [19, 20]. However,
preparedness for the possibility of such events and man-
agement of airway emergencies is a critical component of
the ESM-Ketamine training package.
To further reduce the risk of adverse events, the po-
tential for medication error was minimized through the
use of a standard dosing protocol, with an initial keta-
mine dose of 2 mg/kg administered strictly over a period
of 30 to 60 s. This dose is within the range reported in
the pediatric literature, where dosing generally ranges
from 1 to 2 mg/kg [21, 22]. By standardizing initial dosing
at 2 mg/kg for all ages and all procedures and then allowing
up-titration in 0.5 mg/kg increments, our protocol both
minimized risk of error while allowing for variation in
patient responses to sedation, as well as length and type of
procedure. Standard dosing also simplifies the regimen for
the non-anesthetist providers for whom this training pack-
age was designed.
ESM-Ketamine anesthesia was utilized for a broad
range of painful emergent and urgent pediatric proce-
dures as well as more significant surgeries. As such, this
package addresses two common gaps in the resource-
limited setting: a void in options for analgesia for painful
procedures as well as the paucity of available anesthesia
services. The three most common procedures for which
ketamine was used in our series were the following:
closed orthopedic reduction, debridement of burns, and
incision and drainage of abscesses. While none of these
represent a major surgery, each of these represents a sig-
nificantly painful procedure. The standard of care in
children is to provide procedural sedation for such cases
[20]. The use of the ESM-Ketamine package allowed for
these procedures to be carried out without pain for the
children in our study. In addition, our pediatric case series
included two cases of exploratory laparotomy, two cases
of open fracture reduction, and three cesarean sections.
These surgeries, which require general anesthesia, were
safely completed using ketamine when an anesthetist
could not be present.
Further support for the importance of utilizing ESM-
Ketamine to fill the gap in both analgesia and anesthesia
for pediatric patients is evident in the responses to the
provider surveys in our study. As reported by providers,
without this package, approximately one third of the pa-
tients would have had their procedure completed with-
out any analgesia or anesthesia. This would have likely
led to considerable pain for the child, increased difficulty
with completing the procedure, and psychological stress
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for the child and his/her caretaker(s). Another one third
of the children in our study would have received only di-
azepam and/or paracetamol, ibuprofen, or diclofenac for
pain control prior to procedure, which can lead to the
same negative consequences. The remaining one third of
patients would have had their procedure postponed for a
variable duration, either due to the wait for an
anesthetist to arrive or the time needed to attempt trans-
fer of the patient to another facility, which may occur
with significant delay and difficulty. In some of the cases,
a delay in care could increase the risk of significant mor-
bidity or mortality for the patient. Provider surveys sup-
port that ESM-Ketamine added an essential resource to
prevent these adverse outcomes and provide safe, timely
anesthesia and analgesia for pediatric patients undergo-
ing surgeries and painful procedures in a limited-
resource setting. Undoubtedly, these procedures could
be performed to a higher quality with adequate analgesia
and sedation than without it.
Our study had a number of limitations. Firstly, the
sample size was relatively small. Given the infrequency
with which adverse events occur with ketamine, a very
large sample size would be required to understand how
significant complications are managed in the rare cir-
cumstances in which they occur after ESM-Ketamine
training. Secondly, only providers were surveyed for this
study; patients and parents receiving this anesthesia
package were not asked about their perception of the
medication or whether they or their child experienced
pain during the procedures. With regard to acceptance
of the ESM-Ketamine package as obtained by interview
with providers, there may have been a risk for social de-
sirability bias. Efforts were made to mitigate this bias by
explaining to participants that responses were confiden-
tial and anonymous and that the purpose of the inter-
views was to identify both successes and shortcomings
of the intervention.
This study was conducted within four of the seven
trained facilities in Western Kenya. Although these facil-
ities represent differently sized facilities at different
levels of the health system in Western Kenya, the find-
ings of this study may not necessarily be generalizable to
other low- and middle-income country settings. Further
research examining the applicability of the ESM-
Ketamine package in other resource-limited settings and
countries would, therefore, be useful.
Conclusions
Our study supports that ketamine’s well-established
safety profile for pediatric anesthesia and sedation can
be extended to a setting with limited resources with
the ESM-Ketamine package which standardizes and
packages training, drug delivery, and patient monitor-
ing for non-anesthetist providers. This package, once
implemented, can be used for select surgeries and
painful procedures in children that might otherwise
be performed with little or no analgesia and anesthesia or
significantly delayed. It empowers non-anesthetist pro-
viders to be able to provide safe and effective analgesia
and anesthesia to pediatric patients in emergent and ur-
gent circumstances. The ESM-Ketamine package was
well-accepted by providers trained in its use, evidenced by
the reports they would continue to use this package in fu-
ture procedures. As such, this package addresses a major
gap in analgesia and anesthesia services for children in
resource-limited settings. Further research should con-
tinue to monitor the safety of this package in children
across a larger number of patients as well as explore the
applicability and feasibility of ESM-Ketamine in additional
low-income settings where the need to address the gap in
pediatric anesthesia and analgesia remains great.
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